Todd Matthew Morgan, MD

Associate Professor, Urology | Chief, Division of Urologic Oncology, Urology

Research Area: Dr. Morgan has a translational research laboratory focused on identifying biomarkers associated with treatment response, primarily through molecular profiling of tumor cells circulating in the blood and bone marrow of men with prostate cancer. The goal of this work is to be able to use a “liquid biopsy” to inform decisions in the same way that tissue-based biopsies currently do. These efforts also seek to shed light on how tumors learn to evade certain treatments and how these resistance mechanisms can be targeted. Dr. Morgan also directs a number of clinical trials, primarily focused on understanding how cancer biomarkers can be utilized in order to provide more individualized management approaches. His research has received funding from the National Cancer Institute (NCI), the Department of Defense, the Prostate Cancer Foundation, the Taubman Institute, and the National Comprehensive Cancer Network, among others. 

Email: tomorgan@med.umich.edu

Zachery Roger Reichert, MD, PhD

Assistant Professor, Internal Medicine Hematology Oncology

Email: zreiche@med.umich.edu

Amy Kasputis, BS

Clinical Research Coordinator/Lab Manager

Research Area: Amy works on several clinical studies, including those advanced prostate cancer patients and the Canary Prostate Active Surveillance Study (PASS), Prostate Cancer Risk Clinic (PCRC), and MiCOPilot studies. 

Email: amgursky@med.umich.edu 

Udit Singhal, MD

Chief Resident, Urology

Email: usinghal@med.umich.edu

Jennie Lovett, PhD

Research Area Specialist Intermediate

Research Area: Jennie is the newest member of the lab and analyzes circulating tumor cell expression of androgen-receptor and DNA repair pathway genes from participants in ongoing collaborative studies including ASCLEPIuS, BRCAAWAY, FORCE, MiCoPilot, and TRAP. 

Email: jllovett@med.umich.edu 

Linda Drnek, CCRP

Clinical Research Coordinator

Research Area: Linda is the project manager for the GMAJOR Study, GMAJOR is the second multi-site trial run through the MUSIC Collaborative. GMAJOR is a randomized controlled multi-center study for men with newly diagnosed favorable risk prostate cancer. She has worked with the Urology department for over 40 years on several studies through out the years.

Email: lagius@med.umich.edu 

Derrian Cooley, BS, MSA

Clinical Research Coordinator

Research Area: Sentinel Trial, a non-randomized, large-scale observational trial designed to evaluate the ability of circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) testing to detect recurrence in advance of standard-of-care techniques across solid tumors, and determine the clinical benefit of therapy in ctDNA-positive participants. 

Email: decooley@med.umich.edu 

Kristin Juckette, BS 

Clinical Research Coordinator

Research Area: Kristin is the clinical research coordinator for the GMAJOR study. GMAJOR is the second multi-site trial run through the MUSIC Collaborative. GMAJOR is a randomized controlled multi-center study for men with newly diagnosed favorable risk prostate cancer.

Email: thomkris@med.umich.edu  

Mariana Seymore, BS

Research Assistant

Research Area: Prostate Active Surveillance Study, a study with selective intervention in patients helping to determine the proportion of patients on active surveillance discovering and confirming biomarkers that predict aggressive disease as defined by pre-specified histological, clinical criteria, or outcomes based on these variables. 

Email: seymorem@med.umich.edu